Jeevan Scientific successfully completes USFDA audit with zero observations

13 Jun 2017

Jeevan Scientific Technology (JST) has completed the audit conducted by USFDA at its corporate and clinical pharmacology centre facilities. No 483 observations were issued to the company.

The US Food and Drug Administration (USFDA) had conducted an un-announced audit at the company’s corporate and clinical pharmacology centre facilities. The purpose of this audit was to review the BA/BE studies. The auditor started the review on Jun 05, 2017 and completed on Jun 08, 2017.

Jeevan Scientific Technology provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.



Related Jeevan Scientific Technology Ltd. Links:

Jeevan Scientific Share Price

17.80 0.00 (0.00%) Nov 19, 18:01
1 Year Price Chart
Peers
Company Name CMP
TCS 2108.30
Infosys 712.80
HCL Tech. 1134.70
Wipro 250.40
Tech Mahindra 763.25
View more..
Sensex vs Jeevan Scientific
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463